Network Pharmacology Reveals the Therapeutic Potential of BBB-Permeable Compounds from Lonicera caerulea for Alzheimer’s Disease and Lipid Metabolism Disorders
International Journal of Molecular Sciences · 19.05.2026 · 27 (10) · 4556
DOI: 10.3390/ijms27104556 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.05.2026. Verfasst von Jiayi He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Harbin Medical University, Harbin 150086, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Blood-Brain Barrier, Lonicera, Lipid Metabolism Disorders. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Research and Development Program of Heilongjiang Province, the Industry-University Co-operation Project of the Natural Science Foundation of Heilongjiang Province, Key Project of "14th Five-Year" Plan for Heilongjiang Provincial Educational Science Research in 2025.
Themen: Demenz
Abstract (Originalsprache)
Although risk factors for Alzheimer’s disease (AD) involve obesity and elevated low-density lipoprotein (LDL) cholesterol levels, and Lonicera caerulea has been reported to improve lipid metabolism disorders (LMDs), it remains unknown whether Lonicera caerulea can simultaneously modulate the progression of both AD and LMDs. In this study, an integrative strategy combining network pharmacology, Mendelian randomization (MR), molecular docking, and molecular dynamics simulations was employed to explore potential targets, pathways, and causal relationships. Network pharmacology and molecular docking results revealed that several blood–brain barrier (BBB)-permeable active components of Lonicera caerulea, including Naringenin and Palmatine, may be associated with targets involved in the lipid and atherosclerosis pathway, such as HSP90AA1, SRC and TNF. These associations indicate a potential link between the modulation of lipid metabolism and AD-related processes, although further validation is required. Molecular dynamics simulations were conducted to support the stability of key docking complexes. Given that elevated LDL is a central feature of LMDs and a key indicator of cholesterol imbalance, MR analysis was conducted to assess its causal relationship with AD. The results provided genetic evidence supporting a causal role of elevated LDL in AD risk, reinforcing the epidemiological link between lipid metabolism and neurodegeneration. These findings imply that BBB-permeable constituents of Lonicera caerulea may exert multi-target effects relevant to AD and LMDs. Enrichment analysis further indicates a possible involvement of pathways associated with lipid and atherosclerosis, supporting its potential as a dietary strategy for at-risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Harbin Medical University, Harbin 150086, China.
- Translational Medicine Center of Northern China, Harbin 150086, China.
- Key Laboratory of Biology and Genetic Improvement of Horticultural Crops (Northeast Region), Ministry of Agriculture and Rural Affairs, College of Horticulture and Landscape Architecture, Northeast Agricultural Universi…
- National-Local Joint Engineering Research Center for Development and Utilization of Small Fruits in Cold Regions, National Development and Reform Commission, Harbin 150030, China.
ORCID-Profile: Jiayi He, Jihong Li, Junwei Huo, Yahui Peng
Förderung
- the Key Research and Development Program of Heilongjiang Province
- the Industry-University Co-operation Project of the Natural Science Foundation of Heilongjiang Province
- Key Project of "14th Five-Year" Plan for Heilongjiang Provincial Educational Science Research in 2025
- Special Support Program for "Excellent Physician Training Research" of Harbin Medical Univer-sity in 2025
- Key R&D Program of China
- Key Research and Development Program of Heilongjiang Province
- Natural Science Foundation of Heilongjiang Province
- Key Project of “14th Five-Year” Plan for Heilongjiang Provincial Educational Science Research
Zitieren
APA
He, J., Li, J., Huo, J., Pang, Y., Sun, K., Zhu, H., He, Y., Ren, Z., Cheng, X., Ao, S., & Peng, Y. (2026). Network Pharmacology Reveals the Therapeutic Potential of BBB-Permeable Compounds from Lonicera caerulea for Alzheimer’s Disease and Lipid Metabolism Disorders. International Journal of Molecular Sciences, 27(10), 4556. https://doi.org/10.3390/ijms27104556
Vancouver
He J, Li J, Huo J, Pang Y, Sun K, Zhu H, et al. Network Pharmacology Reveals the Therapeutic Potential of BBB-Permeable Compounds from Lonicera caerulea for Alzheimer’s Disease and Lipid Metabolism Disorders. International Journal of Molecular Sciences. 2026;27(10):4556. doi:10.3390/ijms27104556
BibTeX
@article{He2026,
author = {He, Jiayi and Li, Jihong and Huo, Junwei and Pang, Yijun and Sun, Kaiqi and Zhu, Haoyu and He, Yuhan and Ren, Zhixuan and Cheng, Xin and Ao, Shuang and Peng, Yahui},
title = {Network Pharmacology Reveals the Therapeutic Potential of BBB-Permeable Compounds from Lonicera caerulea for Alzheimer’s Disease and Lipid Metabolism Disorders},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4556},
doi = {10.3390/ijms27104556}
}
EUVIMED